About the Project
PLEASE NOTE THIS PROJECT IS CURRENTLY RESTRICTED TO APPLICANTS WHO ARE ABLE TO COMMENCE ONSHORE IN AUSTRALIA
The University of Queensland Diamantina Institute (UQDI) is a world-leading biomedical translational research facility based at the Translational Research Institute (TRI), on the Princess Alexandra Hospital campus in Brisbane, Australia.
The Institute’s advantageous location allows us to bring together leading biomedical researchers with clinician scientists, creating a central point of expertise, driven to translate findings from model systems to the development of new therapies and clinical practice.
Our researchers work across a range of diseases including cancers, immunological disorders such as arthritis and diabetes, and we have particular strength in genomic medicine. Some of our research highlights to date include discoveries such as the cervical cancer vaccine by Professor Ian Frazer, and a world-first rheumatoid arthritis vaccine, developed by Professor Ranjeny Thomas.
Research at UQDI focuses on developing a better understanding of the molecular and cellular basis of disease, and to translate that understanding to practical outcomes for patients. The Institute covers a wide range of diseases including:
- Autoimmunity (arthritis, diabetes, multiple sclerosis, osteoporosis, ankylosing spondylitis)
- Cancer (blood, brain, cervical, head and neck, melanoma, prostate, skin)
- Infection (viral and bacterial)
- Bone disorders (osteoporosis, skeletal dysplasias)
- Neurological diseases (motor neurone disease, epilepsy, schizophrenia).
The Institute promotes academic freedom to inspire the creativity needed to find different and novel approaches to problems. UQDI has world-leading technologies as well as other state-of-the-art facilities and equipment.
Access to infrastructure
Researchers from around the world are drawn to UQDI for its cutting-edge research infrastructure and strong community of researchers and students working together. We are located at the Translational Research Institute (TRI), a $360M collaborative biomedical translational facility that houses 700 researchers working on the full spectrum of translational medical research.
UQDI provides an innovative research environment ideally suited to research higher degree training. As a research student, you will be mentored by internationally renowned researchers who will guide you in the art of experimentation, project management, communication skills and comprehension of the research field, and future career management. By studying at UQDI, you will be part of a community of prestigious researchers and clinicians working on clinically-relevant problems faced daily by the patients they treat. Our graduates have a diverse skillset and benefit from a training program that prepares them for employment in a range of research environments.
Join us on our journey
We are eager to find passionate researchers to help us lead the way in translational research. The Institute offers a number of positions and scholarships to attract high-calibre researchers and students to UQDI.
Our list of researchers and their projects can be found online. Should you have any questions regarding a researcher or their work, please feel free to send them an email through the contact details provided. They will be more than happy to answer any questions you might have.
UQDI seeks to discover better treatments and therapies to target diseases that severely affect human health. email@example.com
Why not add a message here
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.